Relmada Therapeutics, Inc. RLMD Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s enterprise value?
- Relmada Therapeutics, Inc. (RLMD) reported enterprise value of $163.63M in Q2 2023.
- How has Relmada Therapeutics, Inc.'s enterprise value changed year-over-year?
- Relmada Therapeutics, Inc.'s enterprise value decreased by 76.9% year-over-year, from $706.96M to $163.63M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.